Skip to main content
Clinical Trials/NCT00991185
NCT00991185
Completed
Not Applicable

CSF Pharmacokinetics of Antimicrobials in Children

Duke University1 site in 1 country8 target enrollmentJuly 2009
ConditionsInfections

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infections
Sponsor
Duke University
Enrollment
8
Locations
1
Primary Endpoint
CSF:Serum Ratio of Vancomycin
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to learn more about antimicrobials, especially drug levels in the CSF that would normally be used in young children as part of standard care. These drugs are approved by the Food and Drug Administration (FDA) for treating infections. They are used extensively in children in the United States, but they have not been extensively studied in children or babies. The investigators do not have very much information on how children and babies handle these drugs; that is, how long it takes for the drugs to be removed from the blood circulation and to pass out of the body and how much goes into the central nervous system. The investigators also do not have good information to guide how often the investigators should give the drugs to children and babies to get the maximum effect on infections with the minimum amount of drug. Thus, the investigators will collect more information about how these drugs should be used in children and babies by doing this drug levels research study.

Registry
clinicaltrials.gov
Start Date
July 2009
End Date
April 2014
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children receiving antimicrobial agents and having cerebrospinal fluid collected as part of standard of care

Exclusion Criteria

  • Lack of consent

Outcomes

Primary Outcomes

CSF:Serum Ratio of Vancomycin

Time Frame: within 1 week of drug administration

CSF:serum ration of vancomycin

Study Sites (1)

Loading locations...

Similar Trials